MSC Choc: Injecting allogenic stem cells to treat septic shock

An innovation that brings to you:

• Cellular therapy.

How does it work?

This technique consists in isolating and characterizing a donor bone marrow stem cells to inject it to a patient experiencing the first stages of a septic shock (disproportionate answer of the immune system to an infection: 40 000 deaths in France).

These stem cells, apart from their regenerative capacity, exhibit an activity of local immunomodulation, of monocytic reprogramming, and of organ dysfunction attenuation.

What is it for?

• Septic shock treatment by stem cells injection;
• Cellular therapy.

Innovation availability: 

• Patent licensing.

Target markets:

• Hospital resuscitation;
• Regenerative medicine.